Loss to follow-up in “test and treat era” and its predictors among HIV-positive adults receiving ART in Northwest Ethiopia: Institution-based cohort study

BACKGROUND: People living with HIV/AIDS are enrolled in lifelong Anti-Retroviral Treatment (ART) irrespective of their clinical staging as well as CD4 cell count. Although this “Universal Test and Treat” strategy of ART was found to have numerous benefits, loss from follow-up and poor retention rema...

Descripción completa

Detalles Bibliográficos
Autores principales: Bantie, Berihun, Seid, Awole, Kerebeh, Gashaw, Alebel, Animut, Dessie, Getenet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557930/
https://www.ncbi.nlm.nih.gov/pubmed/36249247
http://dx.doi.org/10.3389/fpubh.2022.876430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557930/
https://www.ncbi.nlm.nih.gov/pubmed/36249247
http://dx.doi.org/10.3389/fpubh.2022.876430

Ejemplares similares